Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Oct;19(10):676.
doi: 10.1038/s41584-023-01014-3.

Reply to: Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?

Janet E Pope  1   2
Affiliations
Comment

Reply to: Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?

Janet E Pope. Nat Rev Rheumatol. 2023 Oct.
No abstract available

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

References

    1. Pope, J. E. et al. State-of-the-art evidence in the treatment of systemic sclerosis. Nat. Rev. Rheumatol. 19, 212–226 (2023). - DOI - PubMed - PMC
    1. Andréasson, K. et al. Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading? Nat. Rev. Rheumatol. https://doi.org/10.1038/s41584-023-01013-4 (2023). - DOI - PubMed
    1. Nambiar, A. M., Anzueto, A. R. & Peters, J. I. Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis. PLoS ONE 12, e0176312 (2017). - DOI - PubMed - PMC
    1. Wigén, J., Elowsson-Rendin, L., Karlsson, L., Tykesson, E. & Westergren-Thorsson, G. Glycosaminoglycans: a link between development and regeneration in the lung. Stem Cells Dev. 28, 823–832 (2019). - DOI - PubMed
    1. Lescoat, A. et al. Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: perspectives for scleroderma-associated interstitial lung disease. Biochem. Pharmacol. 178, 114103 (2020). - DOI - PubMed

Substances

LinkOut - more resources